What is the main business of Lattliv?

The main business activity of Lattliv focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 30, 2020.

Where is the headquarters located?

The headquarters is located at: Słupno.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.

What was the revenue?

In 2021, the company generated total revenue of $94,752, representing an increase of 684.4% compared to 2020.

Is the company profitable?

No, the company recorded a net loss of $36,553 in 2021. For comparison, in 2020 the loss was $47,516, meaning the company reduced its loss by 23.8%.

What is the main operating cost?

The largest operating cost category falls under depreciation and amortization. This category amounted to $37,153 in 2021, representing 28% of all operating expenses.

Lattlivsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-01-30

Share capital

5,000.00 PLN

Registered address

Słupno, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2022 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2021, 123 days late).

2022not filed
202115/11/2022
202020/07/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2021.

Results vs industry

Revenue

This companyUSD 94.75kMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD -36.55kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 131.07kMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 232.35kMedianUSD 883.09kAverageUSD 31.39m

Industry

Authorized Representatives

Iryna Olshevska – President of the Management Board

Manner of representation

If the management board is multi-member, the joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required to submit declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Iryna Olshevskaage 47	49	$661.80	49%
Mykola Skinder	51	$688.82	51%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-08-05 to 2023-03-28.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

2 closed proceedings recorded in KRZ history.

Registration date	Proceeding type	Status
Oct 11, 2025	Discontinued enforcement proceedings	Closed
Mar 31, 2025	Discontinued enforcement proceedings	Closed

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
BiotonS.A.	$72,911,351.08	bioton.com
Celon PharmaS.A.	$52,550,739.16	celonpharma.com
VercoS.A.	$43,577,172.02	verco.com.pl
VipharmS.A.	$30,660,173.61	vipharm.pl
MedicofarmaS.A.	$8,530,473.72	medicofarma.pl
VitamaS.A.	$4,287,087.38	vitama.pl
Munar PharmaS.A.	$85,649.72	munar.pl
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com

Change history

Date	Event
2026-07-23	Address change (Ul. St. Moniuszki 13, 05-250, Słupno → Słupno)
2022-09-15	Address change (Ul. Wolska 14, 05-860, Wolskie → Ul. St. Moniuszki 13, 05-250, Słupno)
2020-10-21	Address change (Ul. Tomasza Zana 43/2.1, 20-601, Lublin → Ul. Wolska 14, 05-860, Wolskie)
2020-10-21	PKD change (Removed: 32.12.Z; Added: 21.20.Z)
2020-01-30	Entered in the register

FAQ

Last updated: 2026-07-23